These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9818551)

  • 1. Pertussis infection and vaccination induces Th1 cells.
    Brady MT; Mahon BP; Mills KH
    Immunol Today; 1998 Nov; 19(11):534. PubMed ID: 9818551
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of Bordetella pertussis.
    He Q
    Pediatr Infect Dis J; 2016 Aug; 35(8):915-7. PubMed ID: 27213264
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of pertactin in pertussis vaccines: the jury is still out.
    Desauziers E; Danve B; Decker MD; Veitch K
    J Infect Dis; 2004 Apr; 189(7):1332-3; author reply 1333-5. PubMed ID: 15031804
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoprophylaxis in pertussis.
    Deb M
    J Commun Dis; 1984 Mar; 16(1):54-60. PubMed ID: 12055788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of whooping cough bacterium may reduce vaccine effectiveness.
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(6):1430. PubMed ID: 25396233
    [No Abstract]   [Full Text] [Related]  

  • 6. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
    Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
    Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular immune response to Bordetella pertussis in two children with whooping cough.
    Hafler JP; Pohl-Koppe A
    Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Components of acellular pertussis vaccines.
    Preston NW; Matthews RC
    Lancet; 1996 Mar; 347(9003):764. PubMed ID: 8602023
    [No Abstract]   [Full Text] [Related]  

  • 9. Acellular pertussis vaccines and pertussis resurgence: revise or replace?
    Ausiello CM; Cassone A
    mBio; 2014 Jun; 5(3):e01339-14. PubMed ID: 24917600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The persistence of pertussis and developments in vaccination strategies.
    Heininger U
    Lancet Respir Med; 2015 Sep; 3(9):668-670. PubMed ID: 26380881
    [No Abstract]   [Full Text] [Related]  

  • 11. The advent of recombinant pertussis vaccines.
    Burnette WN
    Biotechnology (N Y); 1990 Nov; 8(11):1002-5. PubMed ID: 1366927
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R; Lønnes T; Møgster B; Berdal BP
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japanese clinical trials with Takeda acellular pertussis vaccine.
    Kuno-Sakai H; Kimura M; Ozaki K; Isomura S; Kamiya H; Nii R; Kato T; Horiuchi K; Syukuda Y; Fujita I
    Tokai J Exp Clin Med; 1988; 13 Suppl():15-9. PubMed ID: 2908519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N; Guiso N
    Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to pertussis. Not all virulence factors are protective antigens.
    Robbins JB; Schneerson R; Bryla DA; Trollfors B; Taranger J; Lagergård T
    Adv Exp Med Biol; 1998; 452():207-18. PubMed ID: 9889975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model.
    Safarchi A; Octavia S; Luu LD; Tay CY; Sintchenko V; Wood N; Marshall H; McIntyre P; Lan R
    Vaccine; 2015 Nov; 33(46):6277-81. PubMed ID: 26432908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.
    Bouchez V; Guiso N
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. As immunity wanes, whooping cough returns.
    Chin TL
    Health Aff (Millwood); 2014 Dec; 33(12):2095-8. PubMed ID: 25489026
    [No Abstract]   [Full Text] [Related]  

  • 19. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenetic significance of Bordetella pertussis toxin].
    Finger H
    Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.